Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase II |
05/06/2018 |
CATALYSIS |
Paclitaxel/Radiotherapy/Cisplatino for cervical cancer |
17/02/2017 |
SSA |
Phase I/II trial with the mutein no alfa of IL-2 |
03/02/2017 |
CIM |
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . |
06/11/2014 |
FINLAY |
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
24/04/2023 |
CBQ |
Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana |
04/10/2023 |
FINLAY |
Phyisician Led CIMAvax-EGF lung biomarkers |
11/03/2021 |
CIM |
Policosanol + aspirin in post-stroke cognitive impairment |
30/06/2021 |
CPN |
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty |
27/12/2016 |
CPN |
Policosanol in patients with pre-hypertension or with grade I hypertension |
30/06/2021 |
CPN |
Policosanol-Atorvastatina for Ictus |
02/09/2013 |
CPN |
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
21/05/2021 |
CIM |
Quality of life and safety of CARMINAL® nutritional supplement in patients with mild or moderate ulcerative colitis |
29/02/2024 |
CATALYSIS |
Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. |
07/03/2024 |
CATALYSIS |
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series |
2012-09-12 |
CIGB |
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory |
09/07/2018 |
CIM |
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients |
15/12/2015 |
CIM |
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer |
08/07/2015 |
CIM |
Rectal Ozone in the COVID-19 treatment |
05/06/2020 |
CPN |
Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients |
15/07/2021 |
CPN |